A software tool to support follow-up care in a French childhood cancer cohort: construction and feasibility.
Adolescent cancer
Chemotherapy
Childhood cancer
Database
Medical tool
Personalized survivorship care plan
Radiotherapy
Survivorship
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
25 Jan 2024
25 Jan 2024
Historique:
received:
10
06
2023
accepted:
08
01
2024
medline:
25
1
2024
pubmed:
25
1
2024
entrez:
24
1
2024
Statut:
epublish
Résumé
Treatment summaries and a personalized survivorship care plans based on internationally approved, organ-specific follow-up care recommendations are essential in preserving the health and quality of life for cancer survivors. Cohorts made up of survivors of childhood cancer have made significant contributions to the understanding of early mortality, somatic late complications, and psychosocial outcomes among former patients. New treatment protocols are needed to enhance survival and reduce the potential risk and severity of late effects, and working with treatment databases is crucial in doing so. In the GOCE (Grand Ouest Cancer de l'Enfant [Western Region Childhood Cancer]) network, in a participative approach, we developed the LOG-after medical tool, on which health data are registered and can be extracted for analysis. Its name emphasizes the tool's goal, referring to 'logiciel' (the French word for software) that focuses on the period "after" the acute phase. This tool is hosted on a certified health data server. Several interfaces have been developed that can be used depending on the user's profile. Here we present this innovative co-constructed tool that takes national aspects into account, including the results of the feasibility/satisfaction study and its perspective. The database contains data relating to 2558 patients, with samples from 1702 of these (66.54%) being held in a tumor bank. The average year in which treatment started was 2015 (ranging from December 1967 to November 2022: 118 patients were treated before 2012 and registered retrospectively when seen in long-term follow-up consultations or for another cancer since November 2021). A short questionnaire was distributed to healthcare professionals using the tool (physicians and research associates or technicians, n = 14), of whom 11 answered and were all satisfied. Access to the patient interface is currently open to 124 former patients. This was initially offered to 30 former patients who were over 15 years old, affected by the disease within the last 5 years, and had agreed to test it. Their opinions were collected by their doctor by e-mail, telephone, or during a consultation in an open-ended question and a non-directive interview. All patients were satisfied with the tool, with interest in testing it in the long term. Some former patients found that the tool provided them with some ease of mind; one, for instance, commented: "I feel lighter. I allow myself to forget. I know I will get a notification when the time comes." Freely available to all users, LOG-after: (1) provides help with determining personalized survivorship care plans for follow-up; (2) builds links with general practitioners; (3) empowers the patient; and (4) enables health data to be exported for analysis. Database URL for presentation: https://youtu.be/2Ga64iausJE.
Sections du résumé
BACKGROUND
BACKGROUND
Treatment summaries and a personalized survivorship care plans based on internationally approved, organ-specific follow-up care recommendations are essential in preserving the health and quality of life for cancer survivors. Cohorts made up of survivors of childhood cancer have made significant contributions to the understanding of early mortality, somatic late complications, and psychosocial outcomes among former patients. New treatment protocols are needed to enhance survival and reduce the potential risk and severity of late effects, and working with treatment databases is crucial in doing so.
CONSTRUCTION AND CONTENT
UNASSIGNED
In the GOCE (Grand Ouest Cancer de l'Enfant [Western Region Childhood Cancer]) network, in a participative approach, we developed the LOG-after medical tool, on which health data are registered and can be extracted for analysis. Its name emphasizes the tool's goal, referring to 'logiciel' (the French word for software) that focuses on the period "after" the acute phase. This tool is hosted on a certified health data server. Several interfaces have been developed that can be used depending on the user's profile. Here we present this innovative co-constructed tool that takes national aspects into account, including the results of the feasibility/satisfaction study and its perspective.
UTILITY AND DISCUSSION
CONCLUSIONS
The database contains data relating to 2558 patients, with samples from 1702 of these (66.54%) being held in a tumor bank. The average year in which treatment started was 2015 (ranging from December 1967 to November 2022: 118 patients were treated before 2012 and registered retrospectively when seen in long-term follow-up consultations or for another cancer since November 2021). A short questionnaire was distributed to healthcare professionals using the tool (physicians and research associates or technicians, n = 14), of whom 11 answered and were all satisfied. Access to the patient interface is currently open to 124 former patients. This was initially offered to 30 former patients who were over 15 years old, affected by the disease within the last 5 years, and had agreed to test it. Their opinions were collected by their doctor by e-mail, telephone, or during a consultation in an open-ended question and a non-directive interview. All patients were satisfied with the tool, with interest in testing it in the long term. Some former patients found that the tool provided them with some ease of mind; one, for instance, commented: "I feel lighter. I allow myself to forget. I know I will get a notification when the time comes."
CONCLUSIONS
CONCLUSIONS
Freely available to all users, LOG-after: (1) provides help with determining personalized survivorship care plans for follow-up; (2) builds links with general practitioners; (3) empowers the patient; and (4) enables health data to be exported for analysis. Database URL for presentation: https://youtu.be/2Ga64iausJE.
Identifiants
pubmed: 38267891
doi: 10.1186/s12885-024-11857-y
pii: 10.1186/s12885-024-11857-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
130Informations de copyright
© 2024. The Author(s).
Références
Poulalhon C, Goujon S, Marquant F, Faure L, Guissou S, Bonaventure A, Desandes E, Rios P, Lacour B, Clavel J. Factors associated with 5- and 10-year survival among a recent cohort of childhood cancer survivors (France, 2000–2015). Cancer Epidemiol. 2021;73:101950.
doi: 10.1016/j.canep.2021.101950
pubmed: 34214767
Berger C, El Fayech C, Pacquement H, Demoor-Goldschmidt C, Ducassou S, Ansoborlo S, Defachelles AS. Objectives and organization for the long-term follow-up after childhood cancer. Bull Cancer. 2015;102(7–8):579–85.
doi: 10.1016/j.bulcan.2015.03.022
pubmed: 26044987
van Kalsbeek RJ, van der Pal HJH, Kremer LCM, Bardi E, Brown MC, Effeney R, Winther JF, Follin C, den Hartogh J, Haupt R, et al. European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer. Eur J Cancer. 2021;154:316–28.
doi: 10.1016/j.ejca.2021.06.004
pubmed: 34333209
van Kalsbeek RJ, van der Pal HJH, Hjorth L, Winther JF, Michel G, Haupt R, Uyttebroeck A, O’Brien K, Kepakova K, Follin C, et al. The European multistakeholder PanCareFollowUp project: novel, person-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for cancer survivors and caregivers. Eur J Cancer. 2021;153:74–85.
doi: 10.1016/j.ejca.2021.05.030
pubmed: 34153717
van Kalsbeek RJ, Mulder RL, Skinner R, Kremer LCM. The Concept of Cancer Survivorship and Models for Long-Term Follow-Up. Front Horm Res. 2021;54:1–15.
doi: 10.1159/000514693
pubmed: 33895743
Michel G, Mulder RL, van der Pal HJH, Skinner R, Bardi E, Brown MC, Vetsch J, Frey E, Windsor R, Kremer LCM, et al. Evidence-based recommendations for the organization of long-term follow-up care for childhood and adolescent cancer survivors: a report from the PanCareSurFup Guidelines Working Group. J Cancer Surviv. 2019;13(5):759–72.
doi: 10.1007/s11764-019-00795-5
pubmed: 31396878
Alfano CM, Mayer DK, Bhatia S, Maher J, Scott JM, Nekhlyudov L, Merrill JK, Henderson TO. Implementing personalized pathways for cancer follow-up care in the United States: Proceedings from an American Cancer Society-American Society of Clinical Oncology summit. CA Cancer J Clin. 2019;69(3):234–47.
doi: 10.3322/caac.21558
pubmed: 30849190
pmcid: 7376887
Landier W, Skinner R, Wallace WH, Hjorth L, Mulder RL, Wong FL, Yasui Y, Bhakta N, Constine LS, Bhatia S, et al. Surveillance for Late Effects in Childhood Cancer Survivors. J Clin Oncol. 2018;36(21):2216–22.
doi: 10.1200/JCO.2017.77.0180
pubmed: 29874139
pmcid: 6804892
Signorelli C, Wakefield CE, McLoone JK, Fardell JE, Lawrence RA, Osborn M, Truscott J, Tapp H, Cohn RJ, Group ASS. Models of childhood cancer survivorship care in Australia and New Zealand: Strengths and challenges. Asia Pac J Clin Oncol. 2017;13(6):407–15.
doi: 10.1111/ajco.12700
Mulder RL, van Kalsbeek RJ, Hudson MM, Skinner R, Kremer LCM. The Critical Role of Clinical Practice Guidelines and Indicators in High-Quality Survivorship After Childhood Cancer. Pediatr Clin North Am. 2020;67(6):1069–81.
doi: 10.1016/j.pcl.2020.07.003
pubmed: 33131535
Chow EJ, Ness KK, Armstrong GT, Bhakta N, Yeh JM, Bhatia S, Landier W, Constine LS, Hudson MM, Nathan PC. Current and coming challenges in the management of the survivorship population. Semin Oncol. 2020;47(1):23–39.
doi: 10.1053/j.seminoncol.2020.02.007
pubmed: 32197774
pmcid: 7227387
Tonorezos ES, Henderson TO. Clinical Guidelines for the Care of Childhood Cancer Survivors. Children (Basel). 2014;1(2):227–40.
pubmed: 27417477
. In: Childhood Cancer Survivorship: Improving Care and Quality of Life. edn. Edited by Hewitt M, Weiner SL, Simone JV. Washington (DC); 2003.
Murphy P, Levine A, Lerma T, Young S, Hwang J, Goldsby R. A portable survivorship care plan: a tool that helps educate and improve knowledge in childhood cancer survivors. Support Care Cancer. 2021;29(1):169–77.
doi: 10.1007/s00520-020-05422-z
pubmed: 32328773
King JE, O’Connor MC, Shohet E, Krause SM, Scheurer ME, Horowitz ME, Poplack DG, Fordis CM, Gramatges MM. Clinician perceptions of Passport for Care, a web-based clinical decision support tool for survivorship care plan delivery. Pediatr Blood Cancer. 2023;70(1):e30070.
doi: 10.1002/pbc.30070
pubmed: 36326111
Demoor-Goldschmidt C, Drui D, Doutriaux I, Michel G, Auquier P, Dumas A, Berger C, Bernier V, Bohrer S, Bondiau PY, et al. A French national breast and thyroid cancer screening programme for survivors of childhood, adolescent and young adult (CAYA) cancers - DeNaCaPST programme. BMC Cancer. 2017;17(1):326.
doi: 10.1186/s12885-017-3318-1
pubmed: 28499444
pmcid: 5427546
Berbis J, Oudin C, Alessandrini M, Vercasson C, Barlogis V, Chambost H, Michel G, Auquier P. Quality of life in minor siblings of childhood leukemia survivors, long-term after diagnosis: A LEA study (for Leucemies de l’Enfant et de l’Adolescent–childhood and adolescent leukemia). Psychooncology. 2015;24(6):661–8.
doi: 10.1002/pon.3709
pubmed: 25350894
Kremer LC, Mulder RL, Oeffinger KC, Bhatia S, Landier W, Levitt G, Constine LS, Wallace WH, Caron HN, Armenian SH, et al. A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer. 2013;60(4):543–9.
doi: 10.1002/pbc.24445
pubmed: 23281199
Constine LS, Ronckers CM, Hua CH, Olch A, Kremer LCM, Jackson A, Bentzen SM. Pediatric Normal Tissue Effects in the Clinic (PENTEC): An International Collaboration to Analyse Normal Tissue Radiation Dose-Volume Response Relationships for Paediatric Cancer Patients. Clin Oncol (R Coll Radiol). 2019;31(3):199–207.
doi: 10.1016/j.clon.2019.01.002
pubmed: 30670336
Brodeur GM, Nichols KE, Plon SE, Schiffman JD, Malkin D. Pediatric Cancer Predisposition and Surveillance: An Overview, and a Tribute to Alfred G. Knudson Jr Clin Cancer Res. 2017;23(11):e1–5.
doi: 10.1158/1078-0432.CCR-17-0702
Demoor-Goldschmidt C, Bernier V. Towards an improvement of the quality of life after radiotherapy in children. Bull Cancer. 2015;102(7–8):674–83.
doi: 10.1016/j.bulcan.2015.03.007
pubmed: 25882174
Keats MR, Shea K, Parker L, Stewart SA, Flanders A, Bernstein M. After Childhood Cancer: a Qualitative Study of Family Physician, Parent/Guardian, and Survivor Information Needs and Perspectives on Long-Term Follow-up and Survivorship Care Plans. J Cancer Educ. 2019;34(4):638–46.
doi: 10.1007/s13187-018-1349-1
pubmed: 29552704
Haupt R, Essiaf S, Dellacasa C, Ronckers CM, Caruso S, Sugden E, Zadravec Zaletel L, Muraca M, Morsellino V, Kienesberger A, et al. The “Survivorship Passport” for childhood cancer survivors. Eur J Cancer. 2018;102:69–81.
doi: 10.1016/j.ejca.2018.07.006
pubmed: 30138773
Williamson R, Meacham L, Cherven B, Hassen-Schilling L, Edwards P, Palgon M, Espinoza S, Mertens A. Predictors of successful use of a web-based healthcare document storage and sharing system for pediatric cancer survivors: Cancer SurvivorLink. J Cancer Surviv. 2014;8(3):355–63.
doi: 10.1007/s11764-014-0346-6
pubmed: 24535124
Majeed-Ariss R, Baildam E, Campbell M, Chieng A, Fallon D, Hall A, McDonagh JE, Stones SR, Thomson W, Swallow V. Apps and Adolescents: A Systematic Review of Adolescents’ Use of Mobile Phone and Tablet Apps That Support Personal Management of Their Chronic or Long-Term Physical Conditions. J Med Internet Res. 2015;17(12):e287.
doi: 10.2196/jmir.5043
pubmed: 26701961
pmcid: 4704897
Badawy SM, Barrera L, Sinno MG, Kaviany S, O’Dwyer LC, Kuhns LM. Text Messaging and Mobile Phone Apps as Interventions to Improve Adherence in Adolescents With Chronic Health Conditions: A Systematic Review. JMIR Mhealth Uhealth. 2017;5(5):e66.
doi: 10.2196/mhealth.7798
pubmed: 28506955
pmcid: 5447825
Berger C, Casagranda L, Sudour-Bonnange H, Massoubre C, Dalle JH, Teinturier C, Martin-Beuzart S, Guillot P, Lanlo V, Schneider M, et al. Personalized Massive Open Online Course for Childhood Cancer Survivors: Behind the Scenes. Appl Clin Inform. 2021;12(2):237–44.
doi: 10.1055/s-0041-1725185
pubmed: 33763845
pmcid: 7990573
Demoor-Goldschmidt C, Tabone MD, Bernier V, de Vathaire F, Berger C. Long-term follow-up after childhood cancer in France supported by the SFCE-force and weakness-current state, results of a questionnaire and perspectives. Br J Radiol. 2018;91(1084):20170819.
doi: 10.1259/bjr.20170819
pubmed: 29293375
pmcid: 5966008
Rajala S, Jarvela LS, Huurre A, Gronroos M, Rautava P, Lahteenmaki PM. Use of electronic patient data storage for evaluating and setting the risk category of late effects in childhood cancer survivors. Pediatr Blood Cancer. 2020;67(11):e28678.
doi: 10.1002/pbc.28678
pubmed: 32860665
Stevens MCG, Beynon P, Cameron A, Cargill J, Cheshire J, Dolby S. Understanding and Utilizing the Unmet Needs of Teenagers and Young Adults with Cancer to Determine Priorities for Service Development: The Macmillan On Target Programme. J Adolesc Young Adult Oncol. 2018;7(6):652–9.
doi: 10.1089/jayao.2018.0044
pubmed: 29989481